VEGFR2 (Ab 951) Antilichaam

Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions

3791

P35968

NP_002244.1

Human, Mouse, Rat

VEGFR2 (Ab-951) antibody was raised against a peptide sequence around aa.949~953 (K-D-Y-V-G) derived from Human VEGFR2.

Unconjugated

Primary Antibodies

Other

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

None

Blue Ice

Store antibody at -20˚ C for up to one year.

230 kDa

This antibody detects endogenous level of total VEGFR2 protein.

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200

KDR

Kinase insert domain receptor (a type III receptor tyrosine kinase)

Homo sapiens

Zeng H, et al. (2001) J Biol Chem. 276 (35) : 32714-32719. Dougher M, et al. (1999) Oncogene. 18 (8) : 1619-1627.

FLK1, CD309, VEGFR, VEGFR2, CK2A1, FLK1, KDR, VGFR2, VGR2, kinase insert domain receptor

WB, IHC, IF

11321597

Liquid